iCareAb is committed to the development of tumor immunotherapy technology, providing flow cytometry antibodies for multiple popular targets.

Recombinant Proteins

Several recombinant proteins, which are popular targets for tumor immunotherapy, are expressed using mammalian cell lines.

CAR Lentiviral Plasmids

Provide high-quality CAR-T/TCR-T cell drug development services to meet the requirements of in vivo and in vitro pharmacodynamic evaluation experiments.